Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted inducement options to purchase an aggregate of 58,650 shares to two non-executive employees, approved by the independent Compensation Committee on September 8, 2026. The options carry a 10-year term and a $20.46 exercise price, equal to the September 8 closing price, and vest one-fourth on each employee's first anniversary with 1/48th vesting monthly thereafter.
Key figures
- Recipients
- 2
- Exercise price
- 20.46
- Options granted
- 58650
- Option term years
- 10
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.